Log In
BCIQ
Print this Print this
 

PTI-NC-733

  Manage Alerts
Collapse Summary General Information
Company Proteostasis Therapeutics Inc.
DescriptionCombination of PTI-428, a cystic fibrosis transmembrane conductance regulator (CFTR) amplifier, PTI-801, a corrector molecule and PTI-808, a potentiator molecule
Molecular Target Cystic fibrosis transmembrane conductance regulator (CFTR)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today